INSIGHTS

In a recent conversation with Pharmaceutical Technology, BioDuro’s CEO, Dr. Armin Spura, discusses what differentiates our CDMO model, how our global footprint aligns with evolving regulatory landscapes, and the strategic investments shaping our future. The interview offers a high-level look at how BioDuro is redefining partnership and performance in drug development.

Watch the full video to learn how BioDuro is building the future of biopharma manufacturing—globally and with purpose.

We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all